Issue 3/2010
Content (20 Articles)
Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo
Qiang Tan, Jing Li, Han-wei Yin, Li-hui Wang, Wan-chen Tang, Fang Zhao, Xin-min Liu, Hui-hui Zeng
Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols
Madhulika Singh, Shilpa Tyagi, Kulpreet Bhui, Sahdeo Prasad, Yogeshwer Shukla
Silibinin ameliorates oxidative stress induced aberrant crypt foci and lipid peroxidation in 1, 2 dimethylhydrazine induced rat colon cancer
Nagarajan Sangeetha, Selvaraj Aranganathan, Namasivayam Nalini
FBA-TPQ, a novel marine-derived compound as experimental therapy for prostate cancer
Feng Wang, Scharri J. Ezell, Yong Zhang, Wei Wang, Elizabeth R. Rayburn, Dwayaja H. Nadkarni, Srinivasan Murugesan, Sadanandan E. Velu, Ruiwen Zhang
Ongoing DNA synthesis in the rat cerebral cortex is regulated by a proteolytic pathway independent of the proteasome and calpains
J. Sebastián Yakisich, Åke Sidén, Mabel Cruz
Chemopreventive efficacy of gallic acid, an antioxidant and anticarcinogenic polyphenol, against 1,2-dimethyl hydrazine induced rat colon carcinogenesis
Jebakkan Senapathy Giftson, Sathiavelu Jayanthi, Namasivayam Nalini
Development and characterization of CD22-targeted pegylated-liposomal doxorubicin (IL-PLD)
Robert T. O’Donnell, Shiloh M. Martin, Yunpeng Ma, William C. Zamboni, Joseph M. Tuscano
Screening of a PKC ζ-specific kinase inhibitor PKCzI257.3 which inhibits EGF-induced breast cancer cell chemotaxis
Jing Wu, Baogang Zhang, Min Wu, Hongyan Li, Ruifang Niu, Guoguang Ying, Ning Zhang
The PG500 series: novel heparan sulfate mimetics as potent angiogenesis and heparanase inhibitors for cancer therapy
K. Dredge, E. Hammond, K. Davis, C. P. Li, L. Liu, K. Johnstone, P. Handley, N. Wimmer, T. J. Gonda, A. Gautam, V. Ferro, I. Bytheway
Suppression of in vivo tumor growth by using a biodegradable thermosensitive hydrogel polymer containing chemotherapeutic agent
Mi Kyung Kwak, Keun Hur, Ji Eun Yu, Tae Su Han, Kazuyoshi Yanagihara, Woo Ho Kim, Sun Mi Lee, Soo-Chang Song, Han-Kwang Yang
Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants
Jinming Zhou, Guoyan Geng, Jian Hui Wu
Strong inhibition of replicative DNA synthesis in the developing rat cerebral cortex and glioma cells by roscovitine
Juan Sebastian Yakisich, Marina Fernanda Vita, Åke Siden, Deborah Ruth Tasat, Mabel Cruz
Possible contribution of β-glycosidases and caspases in the cytotoxicity of novel glycoconjugates in colon cancer cells
Hossam M. M. Arafa
MMPT: a thiazolidin compound inhibits the growth of lung cancer H1792 cells via Fas-mediated and caspase-dependent apoptosis pathway
Yun-feng Zhao, Xiu-lan Li, Yu-xi Sun, Wen Niu, Zun-li Hu, Lin Lin, Qing-Zhong Kong
Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Brigette B.Y. Ma, Vivian W.Y. Lui, Fan Fong Poon, S.C. Cesar Wong, Ka Fai To, Elaine Wong, Honglin Chen, Kwok Wai Lo, Qian Tao, Anthony T.C. Chan
Phase I, pharmacokinetic study of temsirolimus administered orally to patients with advanced cancer
Jan C. Buckner, Bahram Forouzesh, Charles Erlichman, Manuel Hidalgo, Joseph P. Boni, Gary Dukart, Anna Berkenblit, Eric K. Rowinsky
Pilot study of irinotecan/oxalipltin (IROX) combination chemotherapy for patients with gemcitabine- and 5-fluorouracil- refractory pancreatic cancer
Sung Yong Oh, Hyun Jin Kim, Tae Hyo Kim, Gyeong-Won Lee, Hoon Gu Kim, Chi-Young Jeong, Hyuk-Chan Kwon, Jung Hun Kang
Acute left ventricular dysfunction induced by a panHER and VEGFR tyrosine kinase inhibitor in a phase I trial
Rastislav Bahleda, Christophe Massard, Jean-Charles Soria, Hassan Izzedine, Ariel Cohen, Stéphane Ederhy
Safety and efficacy of panitumumab following cetuximab: retrospective review of the Memorial Sloan-Kettering experience
Derek G. Power, Manish A. Shah, Timothy R . Asmis, Joaquin J . Garcia, Nancy E. Kemeny
Erratum to: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Brigette B. Y. Ma, Vivian W. Y. Lui, Fan Fong Poon, S. C. Cesar Wong, Ka Fai To, Elaine Wong, Honglin Chen, Kwok Wai Lo, Qian Tao, Margaret Heung Ling Ng, Suk Hang Cheng, Anthony T. C. Chan